Literature DB >> 22342460

Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.

Carla S Ceron1, Elen Rizzi, Danielle A Guimaraes, Alisson Martins-Oliveira, Stefany B Cau, Junia Ramos, Raquel F Gerlach, Jose E Tanus-Santos.   

Abstract

Increased vascular matrix metalloproteinases (MMPs) levels play a role in late phases of hypertensive vascular remodeling. However, no previous study has examined the time course of MMPs in the various phases of two-kidney, one-clip hypertension (2K1C). We examined structural vascular changes, collagen and elastin content, vascular oxidative stress, and MMPs levels/activities during the development of 2K1C hypertension. Plasma angiotensin converting enzyme (ACE) activity was measured to assess renin-angiotensin system activation. Sham or 2K1C hypertensive rats were studied after 2, 4, 6, and 10weeks of hypertension. Systolic blood pressure (SBP) was monitored weekly. Morphometry of structural changes in the aortic wall was studied in hematoxylin/eosin, orcein and picrosirius red sections. Aortic NADPH activity and superoxide production was evaluated. Aortic gelatinolytic activity was determined by in situ zymography, and MMP-2, MMP-14, and tissue inhibitor of MMPs (TIMP)-2 levels were determined by gelatin zymography, immunofluorescence and immunohistochemistry. 2K1C hypertension was associated with increased ACE activity, which decreased to normal after 10 weeks. We found increased aortic collagen and elastin content in the early phase of hypertension, which were associated with vascular hypertrophy, increased vascular MMP-2 and MMP-14 (but not TIMP-2) levels, and increased gelatinolytic activity, possibly as a result of increased vascular NADPH oxidase activity and oxidative stress. These results indicate that vascular remodeling of renovascular hypertension is an early process associated with early increases in MMPs activities, enhanced matrix deposition and oxidative stress. Using antioxidants or MMPs inhibitors in the early phase of hypertension may prevent the vascular alterations of hypertension.
Copyright © 2012 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342460     DOI: 10.1016/j.matbio.2012.01.009

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  22 in total

Review 1.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

2.  Combining drugs to optimize the therapy of hypertension: experimental evidence derived from animal models.

Authors:  Danielle A Guimaraes; Jose E Tanus-Santos
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

3.  Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.

Authors:  Raquel C Antonio; Carla S Ceron; Elen Rizzi; Eduardo B Coelho; Jose E Tanus-Santos; Raquel F Gerlach
Journal:  Mol Cell Biochem       Date:  2013-10-10       Impact factor: 3.396

4.  Chronic treatment with C-type natriuretic peptide impacts differently in the aorta of normotensive and hypertensive rats.

Authors:  Carolina Caniffi; Flavia M Cerniello; Gonzalo Bouchet; María L Sueiro; Analía Tomat; Daniel González Maglio; Jorge E Toblli; Cristina Arranz
Journal:  Pflugers Arch       Date:  2019-06-11       Impact factor: 3.657

Review 5.  Role of Thioredoxin in Age-Related Hypertension.

Authors:  Kumuda C Das; Venkatesh Kundumani-Sridharan; Jaganathan Subramani
Journal:  Curr Hypertens Rep       Date:  2018-02-14       Impact factor: 5.369

6.  Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice.

Authors:  Sathnur Pushpakumar; Sourav Kundu; Tyranny Pryor; Srikanth Givvimani; Eleanor Lederer; Suresh C Tyagi; Utpal Sen
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

7.  Augmented vascular smooth muscle cell stiffness and adhesion when hypertension is superimposed on aging.

Authors:  Nancy L Sehgel; Zhe Sun; Zhongkui Hong; William C Hunter; Michael A Hill; Dorothy E Vatner; Stephen F Vatner; Gerald A Meininger
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

8.  Nebivolol Prevents Up-Regulation of Nox2/NADPH Oxidase and Lipoperoxidation in the Early Stages of Ethanol-Induced Cardiac Toxicity.

Authors:  Gabriel T do Vale; Carla B P da Silva; Arthur H Sousa; Natália A Gonzaga; Juliana M Parente; Katiúscia M Araújo; Michele M Castro; Carlos R Tirapelli
Journal:  Cardiovasc Toxicol       Date:  2020-10-16       Impact factor: 3.231

9.  Strength Training Reduces Cardiac and Renal Oxidative Stress in Rats with Renovascular Hypertension.

Authors:  Rodrigo Miguel-Dos-Santos; Jucilene Freitas Dos Santos; Fabricio Nunes Macedo; Anderson Carlos Marçal; Valter J Santana Filho; Rogerio Brandão Wichi; Sandra Lauton-Santos
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

Review 10.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.